Experimental design
. Representative scheme of the experimental design. A multiapproach study of the effect of ~40 nm MUA-coated Au nanospheres and nanostars, 24 h after i.v. administration to Wistar rats.
Characterization of AuNPs
The synthesized AuNPs were characterized using UV-Vis spectrophotometry, transmission electron microscopy (TEM), Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA). The UV-Vis spectra were measured in a range of 300 -1000 nm, at room temperature using a UV-Vis spectrophotometer Varian Cary 50 Bio UV-Visible (Agilent Technologies, Santa Clara, CA, US) in a quartz cell (Starna). Images of the synthesized nanoparticles samples were obtained using a Hitachi H-8100 transmission electron microscope (Hitachi, Tokyo, Japan) operated at 200 kV and the ImageJ software (http://rsbweb.nih.gov/ij/) was applied to calculate the average core diameter and the standard distribution from minimum 100 nanoparticles. The hydrodynamic diameter and zeta potential of the AuNPs were measured by Dynamic Light Scattering (DLS) measurements of size and then zeta potential determinations were performed using a Zetasizer Nano ZS (Malvern Panalytical, Malvern, UK), with a 4 mW He-Ne laser (633 nm), at 25 ºC using disposable capillary cells. The measurements were taken as the average of a minimum of three runs, each containing 11submeasurements and the results are presented as mean z-average (PSD) together with the polydispersity index (PDI). The NTA measurements of the hydrodynamic diameter and of AuNPs concentrations were performed using a NanoSight NS300 instrument (Malvern Panalytical, Malvern, UK) and 50x or 100x diluted (with 10 mM phosphate buffer, pH 7.4) samples. The results are presented as Mean+/-Standard error of the mean.
Quantification of gold in biological samples by Graphite Furnace Atomic Absorption Spectrometry (GFAAS)
The content in gold was analyzed by GFAAS in whole blood, faeces, urine, liver, spleen, lung, heart, kidney, brain, small intestine (duodenum), fat, skeletal muscle (quadriceps femuris) and tail. Briefly, the samples were first digested with a mixture of 5% HNO3 and 30% H2O2 (4:1) at 105 ºC and further analysed using an AAnalyst 600 Atomic Absorption Spectrophotometer (Perkin-Elmer, Shelton, CT, USA) equipped with an auto-sampler. A previous 1:50 dilution with 0.2% HCl was necessary for some of the biological samples. Using an autosampler, 20 μL of standard solution/diluted sample and 10 μL of matrix modifier [3 g/L Pd(NO3)2 + 2 g/L Mg(NO3)2] were injected into the graphite furnace to measure the Au content. All analyses were conducted at 242.8 nm and the Au atomized at 1800 ºC. The readings were taken by using the peak area.
Target organ metabolome analysis

Chromatographic and mass spectrometry settings
The chromatographic analysis was performed using an EVOQ 436 GC system (Bruker Daltonics, Fremont, CA) coupled to a SCION Triple Quadrupole mass detector, using a capillary column Rxi-5Sil MS (30 m*0.25 mm*0.25 μm) from RESTEK. Helium C-60 (Gasin, Portugal) was used as the carrier gas at a constant flow rate of 1.0 mL/min. Samples (2 μL) were injected in split mode (ratio 1:20) and the injector temperature was 250 ºC (held for 20 min). The oven temperature was fixed at 70 ºC for 2 min, then increasing to 250 ºC (rate 15 ºC/min), held for 2 min, then increasing to 300 ºC (rate 10 ºC/min) and held for 5 min. Total separation run time was 26 min. The MS detector was operated in EI mode (70 eV). The transfer line temperature was 280 ºC, manifold temperature was 40 ºC and the EI temperature was 270 ºC. Data acquisition was performed in full scan mode with a mass range between 50 and 400 m/z. A QC sample was repeatedly analyzed under the same conditions, one every nine samples, to guarantee the analytical reproducibility of the method. Sample preparation and GC-MS acquisition were randomized to avoid analytical bias. 
